alt="syringe"

Designing Tomorrow´s Vaccines

SVF develops vaccines and immunotherapies to prevent and treat life-threatening diseases based on technology developed at the Karolinska Institute in Stockholm. A therapeutic vaccine for chronic hepatitis B and D infection, and a prophylactic vaccine targeting both the current COVID-19 pandemic and other coronavirus infections.

Testimonials

“SVF develops a therapeutic vaccine for chronic hepatitis B and D infection, and a prophylactic vaccine targeting both the current COVID-19 pandemic and other coronavirus infections.”

Jens Bäck

CEO and Board Member